Sinopharm Tech Holdings (HKSE:08156) 3-Year FCF Growth Rate : 105.40% (As of Dec. 2023)

View and export this data going back to 2002. Start your Free Trial

What is Sinopharm Tech Holdings 3-Year FCF Growth Rate?

Sinopharm Tech Holdings's Free Cash Flow per Share for the three months ended in Dec. 2023 was HK$0.00.

During the past 3 years, the average Free Cash Flow per Share Growth Rate was 105.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.

During the past 13 years, the highest 3-Year average Free Cash Flow per Share Growth Rate of Sinopharm Tech Holdings was 105.40% per year. The lowest was -136.30% per year. And the median was 13.20% per year.

Competitive Comparison of Sinopharm Tech Holdings's 3-Year FCF Growth Rate

For the Software - Application subindustry, Sinopharm Tech Holdings's 3-Year FCF Growth Rate, along with its competitors' market caps and 3-Year FCF Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sinopharm Tech Holdings's 3-Year FCF Growth Rate Distribution in the Software Industry

For the Software industry and Technology sector, Sinopharm Tech Holdings's 3-Year FCF Growth Rate distribution charts can be found below:

* The bar in red indicates where Sinopharm Tech Holdings's 3-Year FCF Growth Rate falls into.

Sinopharm Tech Holdings 3-Year FCF Growth Rate Calculation

This is the 3-year average growth rate of Free Cash Flow per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.

Sinopharm Tech Holdings (HKSE:08156) 3-Year FCF Growth Rate Explanation

Free Cash Flow per Share is the amount of Free Cash Flow per outstanding share of the company's stock. Free Cash Flow is considered one of the most important parameters to measure a company's earnings power by value investors because it is not subject to estimates of Depreciation, Depletion and Amortization (DDA). However, when we look at the Free Cash Flow, we should look from a long term perspective, because any year's Free Cash Flow can be drastically affected by the spending on Property, Plant, & Equipment (PPE) of the business in that year. Over the long term, Free Cash Flow should give pretty good picture on the real earnings power of the company. It's used in the calculation of Forward Rate of Return (Yacktman) %.

Sinopharm Tech Holdings 3-Year FCF Growth Rate Related Terms

Thank you for viewing the detailed overview of Sinopharm Tech Holdings's 3-Year FCF Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Sinopharm Tech Holdings (HKSE:08156) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Technology » Software » Sinopharm Tech Holdings Ltd (HKSE:08156) » Definitions » 3-Year FCF Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

Ruttonjee Centre, 11 Duddell Street, Unit 1802, 18/F, Ruttonjee House, Hong Kong Central, Hong Kong, HKG

Website

https://www.sinopharmtech.com.hk

Sinopharm Tech Holdings Ltd is an investment holding company. The company's operating segment includes Lottery-related services; Provision of Internet Plus services (solution and supply chain), Manufacturing and distribution of personal protective equipment, and Others services. It generates maximum revenue from the internet plus services (solution and supply chain) segment. The Internet plus Supply chain services segment includes the provision of supply chain management, data analysis and related services, and trading of goods through the internet platform. Geographically, it derives a majority of revenue from Hong Kong.

Executives

Best Frontier Investments Limited
Chan Kin Ho Philip	2201 Interest of corporation controlled by you
Lam Yui Keung	2201 Interest of corporation controlled by you
Sinopharm Traditional Chinese Medicine Overseas Holdings Limited	2101 Beneficial owner
Main Key Investments Limited	2201 Interest of corporation controlled by you
Guo Lei	2201 Interest of corporation controlled by you
Integrated Asset Management (asia) Limited	2101 Beneficial owner
Yam Tak Cheung	2201 Interest of corporation controlled by you
Chan Tung Mei	2202 Interest of your spouse
Cheung Kwai Lan	2201 Interest of corporation controlled by you
Tse Siu Hoi	2101 Beneficial owner
Gam Star China Equity (a Sub-fund Of Gam Star Fund P.l.c.)	2102 Investment manager

Sinopharm Tech Holdings (HKSE:08156) Headlines

No Headlines